Correction to article on growth in 'branded generics'
23 Octubre 2017 - 10:26AM
Noticias Dow Jones
Todd Chermak is Abbott's head of innovation and development for
emerging markets. "Drug Makers Find 'Branded Generics' Are a Source
for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark
in the 24th paragraph. (Oct. 23)
(END) Dow Jones Newswires
October 23, 2017 11:11 ET (15:11 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Hikma Pharmaceuticals plc (PK) (OTCMarkets): 0 recent articles
Más de Hikma Pharmaceuticals Plc. (PC) Artículos de Noticias